Call to arrange a consultation
+1 416 777 0888

Bristol-Myers Squibb Canada Co. et al. v Sandoz Canada Inc.

2019
T-503-19
Pending
New PM(NOC) Regulations

Action under the new Patented Medicines (Notice of Compliance) Regulations regarding Patent No. 2,791,171 (apixaban)

Counsel to: 
Sandoz Canada Inc.
here.

Meet the team